RhumbLine Advisers’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-32,488
| Closed | -$560K | – | 3037 |
|
2019
Q1 | $560K | Sell |
32,488
-270
| -0.8% | -$4.65K | ﹤0.01% | 2285 |
|
2018
Q4 | $419K | Buy |
32,758
+11,022
| +51% | +$141K | ﹤0.01% | 2382 |
|
2018
Q3 | $353K | Sell |
21,736
-11,125
| -34% | -$181K | ﹤0.01% | 2434 |
|
2018
Q2 | $424K | Buy |
32,861
+10,320
| +46% | +$133K | ﹤0.01% | 2377 |
|
2018
Q1 | $281K | Buy |
22,541
+2,595
| +13% | +$32.4K | ﹤0.01% | 2470 |
|
2017
Q4 | $279K | Sell |
19,946
-4,079
| -17% | -$57.1K | ﹤0.01% | 2500 |
|
2017
Q3 | $404K | Sell |
24,025
-475
| -2% | -$7.99K | ﹤0.01% | 2416 |
|
2017
Q2 | $412K | Buy |
24,500
+2,053
| +9% | +$34.5K | ﹤0.01% | 2399 |
|
2017
Q1 | $348K | Buy |
22,447
+1,074
| +5% | +$16.7K | ﹤0.01% | 2432 |
|
2016
Q4 | $320K | Sell |
21,373
-3,407
| -14% | -$51K | ﹤0.01% | 2461 |
|
2016
Q3 | $311K | Buy |
24,780
+600
| +2% | +$7.53K | ﹤0.01% | 2469 |
|
2016
Q2 | $218K | Buy |
24,180
+5,850
| +32% | +$52.7K | ﹤0.01% | 2693 |
|
2016
Q1 | $182K | Buy |
18,330
+110
| +0.6% | +$1.09K | ﹤0.01% | 2761 |
|
2015
Q4 | $210K | Buy |
18,220
+1,860
| +11% | +$21.4K | ﹤0.01% | 2773 |
|
2015
Q3 | $221K | Buy |
16,360
+630
| +4% | +$8.51K | ﹤0.01% | 2735 |
|
2015
Q2 | $218K | Buy |
15,730
+2,650
| +20% | +$36.7K | ﹤0.01% | 2845 |
|
2015
Q1 | $184K | Buy |
+13,080
| New | +$184K | ﹤0.01% | 2852 |
|